Patents by Inventor Timothy J. Curley
Timothy J. Curley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10596358Abstract: Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject.Type: GrantFiled: July 24, 2017Date of Patent: March 24, 2020Assignee: PALO ALTO RESEARCH CENTER INCORPORATEDInventors: David Mathew Johnson, Martin Sheridan, Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn, Philipp H. Schmaelzle
-
Publication number: 20180338904Abstract: Devices and methods are provided for drug delivery. The device may include a housing configured for intralumenal deployment into a human or animal subject and a reservoir contained within the housing and having an actuation end and a release end. The release end may include at least one outlet. A first drug formulation and a second drug formulation may be disposed within the reservoir and adjacent to each other and immiscible, or separated from each other by a first barrier. The device may also include a plug within the reservoir at the actuation end, the plug being movable toward the release end to drive the first and second drug formulations out of the reservoir. The device may also include an actuation system operably connected to the actuation end of the reservoir and configured to drive the plug toward the release end and release the drug formulations from the reservoir.Type: ApplicationFiled: June 1, 2018Publication date: November 29, 2018Applicant: Inguran, LLCInventors: Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley
-
Publication number: 20170319834Abstract: Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Inventors: David Mathew Johnson, Martin Sheridan, Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn, Philipp H. Schmaelzle
-
Patent number: 9744341Abstract: Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject.Type: GrantFiled: January 15, 2013Date of Patent: August 29, 2017Assignee: Palo Alto Research Center IncorporatedInventors: David Mathew Johnson, Martin Sheridan, Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn, Philipp H. Schmaelzle
-
Patent number: 9717526Abstract: Devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and first and second reservoirs within the housing, each reservoir having an actuation end, an opposed release end, and a plug moveable from the actuation end toward the release end. First and second drug formulations may be contained in the first and second reservoirs, respectively. The device may also include one or more actuation systems configured to drive the first and second plugs so as to drive the first and second drug formulations from the first and second reservoirs. The housing may include a porous membrane sidewall in fluid communication with the release ends of the first and second reservoirs, the porous membrane sidewall being configured to distribute the first and second drug formulations driven from the first and second reservoirs.Type: GrantFiled: December 19, 2014Date of Patent: August 1, 2017Assignee: Palo Alto Research Center IncorporatedInventors: Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn
-
Publication number: 20160257417Abstract: Embodiments of a hand-launched solar-powered aircraft are disclosed. In addition, embodiments of kits are disclosed for the construction of a hand-launched solar-powered aircraft. Further, embodiments of methods of making a hand-launched aircraft are disclosed. In some embodiments, the hand-launched aircraft is solar-powered. Still further, embodiments of an educational kit for a hand-launched, solar-powered aircraft are disclosed. In various embodiments, the educational kit comprises educational material on one or more science and technology learning topics, which educational material is relevant to and supplemented by the assembly and/or operation of the aircraft. The education material can relate to, for example, one or more of flying techniques, aeronautics, renewable energy, electronics, mechanical engineering, and/or climatology.Type: ApplicationFiled: September 1, 2014Publication date: September 8, 2016Inventors: Timothy J. CURLEY, Gordon Paul BRADLEY
-
Patent number: 9204895Abstract: Devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and first and second reservoirs within the housing, each reservoir having an actuation end, an opposed release end, and a plug moveable from the actuation end toward the release end. First and second drug formulations may be contained in the first and second reservoirs, respectively. The device may also include one or more actuation systems configured to drive the first and second plugs so as to drive the first and second drug formulations from the first and second reservoirs. The housing may include a porous membrane sidewall in fluid communication with the release ends of the first and second reservoirs, the porous membrane sidewall being configured to distribute the first and second drug formulations driven from the first and second reservoirs.Type: GrantFiled: December 19, 2014Date of Patent: December 8, 2015Assignee: Palo Alto Research Center IncorporatedInventors: Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn
-
Publication number: 20150298017Abstract: Embodiments of a hand-launched solar-powered aircraft are disclosed. In addition, embodiments of kits are disclosed for the construction of a hand-launched solar-powered aircraft. Further, embodiments of methods of making a hand-launched aircraft are disclosed. In some embodiments, the hand-launched aircraft is solar-powered. Still further, embodiments of an educational kit for a hand-launched, solar-powered aircraft are disclosed. In various embodiments, the educational kit comprises educational material on one or more science and technology learning topics, which educational material is relevant to and supplemented by the assembly and/or operation of the aircraft. The education material can relate to, for example, one or more of flying techniques, aeronautics, renewable energy, electronics, mechanical engineering, and/or climatology.Type: ApplicationFiled: April 18, 2014Publication date: October 22, 2015Applicant: TOY LABS, INC.Inventors: Timothy J. CURLEY, Gordon Paul BRADLEY
-
Publication number: 20150105610Abstract: Devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and first and second reservoirs within the housing, each reservoir having an actuation end, an opposed release end, and a plug moveable from the actuation end toward the release end. First and second drug formulations may be contained in the first and second reservoirs, respectively. The device may also include one or more actuation systems configured to drive the first and second plugs so as to drive the first and second drug formulations from the first and second reservoirs. The housing may include a porous membrane sidewall in fluid communication with the release ends of the first and second reservoirs, the porous membrane sidewall being configured to distribute the first and second drug formulations driven from the first and second reservoirs.Type: ApplicationFiled: December 19, 2014Publication date: April 16, 2015Inventors: Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn
-
Publication number: 20150105751Abstract: Devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and first and second reservoirs within the housing, each reservoir having an actuation end, an opposed release end, and a plug moveable from the actuation end toward the release end. First and second drug formulations may be contained in the first and second reservoirs, respectively. The device may also include one or more actuation systems configured to drive the first and second plugs so as to drive the first and second drug formulations from the first and second reservoirs. The housing may include a porous membrane sidewall in fluid communication with the release ends of the first and second reservoirs, the porous membrane sidewall being configured to distribute the first and second drug formulations driven from the first and second reservoirs.Type: ApplicationFiled: December 19, 2014Publication date: April 16, 2015Inventors: Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn
-
Patent number: 9005108Abstract: Devices and methods are provided for drug delivery. The device may include a housing configured for intralumenal deployment into a human or animal subject and first and second reservoirs within the housing, each reservoir having an actuation end, an opposed release end, and a plug moveable from the actuation end toward the release end. First and second drug formulations may be contained in the first and second reservoirs, respectively. The device may also include one or more actuation systems configured to drive the first and second plugs so as to drive the first and second drug formulations from the first and second reservoirs. The housing may include a porous membrane sidewall in fluid communication with the release ends of the first and second reservoirs, the porous membrane sidewall being configured to distribute the first and second drug formulations driven from the first and second reservoirs.Type: GrantFiled: September 27, 2012Date of Patent: April 14, 2015Assignee: Palo Alto Research Center IncorporatedInventors: Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn
-
Publication number: 20140200553Abstract: Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject.Type: ApplicationFiled: January 15, 2013Publication date: July 17, 2014Applicant: PALO ALTO RESEARCH CENTER INCORPORATEDInventors: David Mathew Johnson, Martin Sheridan, Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn, Philipp H. Schmaelzle
-
Publication number: 20140088346Abstract: Devices and methods are provided for drug delivery. The device may include a housing configured for intralumenal deployment into a human or animal subject and first and second reservoirs within the housing, each reservoir having an actuation end, an opposed release end, and a plug moveable from the actuation end toward the release end. First and second drug formulations may be contained in the first and second reservoirs, respectively. The device may also include one or more actuation systems configured to drive the first and second plugs so as to drive the first and second drug formulations from the first and second reservoirs. The housing may include a porous membrane sidewall in fluid communication with the release ends of the first and second reservoirs, the porous membrane sidewall being configured to distribute the first and second drug formulations driven from the first and second reservoirs.Type: ApplicationFiled: September 27, 2012Publication date: March 27, 2014Applicant: PALO ALTO RESEARCH CENTER INCORPORATEDInventors: Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn
-
Publication number: 20140088345Abstract: Devices and methods are provided for drug delivery. The device may include a housing configured for intralumenal deployment into a human or animal subject and a reservoir contained within the housing and having an actuation end and a release end. The release end may include at least one outlet. A first drug formulation and a second drug formulation may be disposed within the reservoir and adjacent to each other and immiscible, or separated from each other by a first barrier. The device may also include a plug within the reservoir at the actuation end, the plug being movable toward the release end to drive the first and second drug formulations out of the reservoir. The device may also include an actuation system operably connected to the actuation end of the reservoir and configured to drive the plug toward the release end and release the drug formulations from the reservoir.Type: ApplicationFiled: September 27, 2012Publication date: March 27, 2014Applicant: PALO ALTO RESEARCH CENTER INCORPORATEDInventors: Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley